Growth Metrics

Ptc Therapeutics (PTCT) Asset Utilization Ratio (2016 - 2025)

Ptc Therapeutics (PTCT) has 13 years of Asset Utilization Ratio data on record, last reported at 0.62 in Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 170.18% year-over-year to 0.62; the TTM value through Dec 2025 reached 0.62, up 170.18%, while the annual FY2025 figure was 0.75, 67.78% up from the prior year.
  • Asset Utilization Ratio reached 0.62 in Q4 2025 per PTCT's latest filing, down from 0.67 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.67 in Q3 2025 and bottomed at 0.16 in Q1 2021.
  • Average Asset Utilization Ratio over 5 years is 0.42, with a median of 0.42 recorded in 2022.
  • Peak YoY movement for Asset Utilization Ratio: crashed 61.11% in 2024, then surged 170.18% in 2025.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.27 in 2021, then soared by 55.97% to 0.43 in 2022, then skyrocketed by 39.58% to 0.59 in 2023, then plummeted by 61.11% to 0.23 in 2024, then soared by 170.18% to 0.62 in 2025.
  • Per Business Quant database, its latest 3 readings for Asset Utilization Ratio were 0.62 in Q4 2025, 0.67 in Q3 2025, and 0.67 in Q2 2025.